Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
- 期刊名称Infection and Drug Resistance
- 作者Huang, Chen; Zheng, Beiwen; Yu, Wei; Niu, Tianshui; Xiao, Tingting; Zhang, Jing; Xiao, Yonghong
- 电子ISSN1178-6973
- 文件大小2160.47KB
- 发表时间2018-01
- DOI10.2147/IDR.S150431
- 页码103-112
Plasmablastic lymphoma: current perspectivesLopez, Andres; Abrisqueta, Pau · Blood and Lymphatic Cancer: Targets and Therapy · 2018
Recent developments in myelofibrosisTibes, Raoul; Bogenberger, James; Mesa, Ruben · Blood and Lymphatic Cancer: Targets and Therapy · 2012
Therapeutic developments in acute lymphoblastic leukemiaKasner, Margie; MacKenzie, · Blood and Lymphatic Cancer: Targets and Therapy · 2012
Targeting CD20 in chronic lymphocytic leukemiaArnason, Jon; Nahas, Myrna · Blood and Lymphatic Cancer: Targets and Therapy · 2015
Novel conditioning regimens for bone marrow transplantationIkehara, Susumu; Shi, Ming; Li, Ming · Blood and Lymphatic Cancer: Targets and Therapy · 2013
Advances in the diagnosis and management of lymphomaMatasar, Matthew; Word, · Blood and Lymphatic Cancer: Targets and Therapy · 2012
Peripheral T cell lymphoma: clinical utility of romidepsinZain, Jasmine; Sawey, · Blood and Lymphatic Cancer: Targets and Therapy · 2012
Coexistence of primary myelofibrosis and chronic lymphocytic leukemiaBurgstaller, Sonja; Thaler, Josef · Blood and Lymphatic Cancer: Targets and Therapy · 2014